Sign In

Login

Password

Forgot Password ? Sign Up

إستراديول (دواء) (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "إستراديول (دواء)" in Arabic language version.

refsWebsite
Global rank Arabic rank
17doi.org
2nd place
5th place
15nih.gov
4th place
6th place
11web.archive.org
1st place
1st place
5books.google.com
3rd place
8th place
5worldcat.org
5th place
4th place
3wikidata.org
43rd place
2nd place
2fda.gov
447th place
393rd place
2archive.org
6th place
3rd place
2clincalc.com
3,912th place
2,538th place
1chemspider.com
8,573rd place
3,029th place
1hormonebalance.org
low place
low place

archive.org

books.google.com

chemspider.com

clincalc.com

doi.org

  • Drug Indications Extracted from FAERS، DOI:10.5281/ZENODO.1435999، QID:Q56863002
  • Kuhl H (2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration" (PDF). Climacteric. 8 Suppl 1: 3–63. DOI:10.1080/13697130500148875. PMID:16112947. مؤرشف من الأصل (PDF) في 2020-01-27.
  • Christin-Maitre S (2017). "Use of Hormone Replacement in Females with Endocrine Disorders". Horm Res Paediatr. ج. 87 ع. 4: 215–223. DOI:10.1159/000457125. PMID:28376481.
  • Christin-Maitre S، Laroche E، Bricaire L (يناير 2013). "A new contraceptive pill containing 17β-estradiol and nomegestrol acetate". Womens Health (Lond). ج. 9 ع. 1: 13–23. DOI:10.2217/whe.12.70. PMID:23241152.
  • Newton JR، D'arcangues C، Hall PE (1994). "A review of "once-a-month" combined injectable contraceptives". J Obstet Gynaecol (Lahore). 4 Suppl 1: S1–34. DOI:10.3109/01443619409027641. PMID:12290848.
  • Wesp LM، Deutsch MB (2017). "Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons". Psychiatr. Clin. North Am. ج. 40 ع. 1: 99–111. DOI:10.1016/j.psc.2016.10.006. PMID:28159148.
  • Ali Shah SI (2015). "Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer". South Asian J Cancer. ج. 4 ع. 2: 95–7. DOI:10.4103/2278-330X.155699. PMC:4418092. PMID:25992351.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
  • Coelingh Bennink HJ، Verhoeven C، Dutman AE، Thijssen J (يناير 2017). "The use of high-dose estrogens for the treatment of breast cancer". Maturitas. ج. 95: 11–23. DOI:10.1016/j.maturitas.2016.10.010. PMID:27889048.
  • Yang Z، Hu Y، Zhang J، Xu L، Zeng R، Kang D (فبراير 2017). "Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis". Gynecol. Endocrinol. ج. 33 ع. 2: 87–92. DOI:10.1080/09513590.2016.1248932. PMID:27898258.
  • Lambrinoudaki I (أبريل 2014). "Progestogens in postmenopausal hormone therapy and the risk of breast cancer". Maturitas. ج. 77 ع. 4: 311–7. DOI:10.1016/j.maturitas.2014.01.001. PMID:24485796.
  • Stege R، Carlström K، Collste L، Eriksson A، Henriksson P، Pousette A (1988). "Single drug polyestradiol phosphate therapy in prostatic cancer". Am. J. Clin. Oncol. 11 Suppl 2: S101–3. DOI:10.1097/00000421-198801102-00024. PMID:3242384.
  • Ockrim JL، Lalani EN، Laniado ME، Carter SS، Abel PD (مايو 2003). "Transdermal estradiol therapy for advanced prostate cancer--forward to the past?". J. Urol. ج. 169 ع. 5: 1735–7. DOI:10.1097/01.ju.0000061024.75334.40. PMID:12686820.
  • Kaufman، C. (1933). "Die Behandlung der Amenorrhöe mit Hohen Dosen der Ovarialhormone". Klinische Wochenschrift. ج. 12 ع. 40: 1557–1562. DOI:10.1007/BF01765673. ISSN:0023-2173.
  • Buschbeck، Herbert (2009). "Neue Wege der Hormontherapie in der Gynäkologie" [New ways of hormonal therapy in gynecology]. Deutsche Medizinische Wochenschrift. ج. 60 ع. 11: 389–393. DOI:10.1055/s-0028-1129842. ISSN:0012-0472.
  • Biskind، Morton S. (1935). "Commercial Glandular Products". Journal of the American Medical Association. ج. 105 ع. 9: 667. DOI:10.1001/jama.1935.92760350007009a. ISSN:0002-9955. Progynon-B, Schering Corporation: This is crystalline hydroxyestrin benzoate obtained by hydrogenation of theelin and subsequent conversion to the benzoate. [...] Progynon-B is marketed in ampules containing 1 cc. of a sesame oil solution of hydroxyestrin benzoate of either 2,500, 5,000, 10,000 or 50,000 international units.
  • "Neue Spezialitäten". Klinische Wochenschrift. ج. 44 ع. 23: 1381. 1966. DOI:10.1007/BF01747900. ISSN:0023-2173. NEUE SPEZIALITATEN [...] Progynova. 1 Dragee enthält 2 mg Oestradiolvalerinat (Klimakterium). Hersteller: Schering AG, Berlin 65.
  • Whedon JM، KizhakkeVeettil A، Rugo NA، Kieffer KA (يناير 2017). "Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis". J Womens Health (Larchmt). ج. 26 ع. 1: 18–28. DOI:10.1089/jwh.2015.5628. PMID:27603786.

fda.gov

accessdata.fda.gov

hormonebalance.org

nih.gov

pubmed.ncbi.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

web.archive.org

wikidata.org

  • Drug Indications Extracted from FAERS، DOI:10.5281/ZENODO.1435999، QID:Q56863002
  • estradiols (بالإنجليزية), QID:Q278487
  • Estra-1(10),2,4-triene-3,17-diol، QID:Q2311683

worldcat.org

  • Kaufman، C. (1933). "Die Behandlung der Amenorrhöe mit Hohen Dosen der Ovarialhormone". Klinische Wochenschrift. ج. 12 ع. 40: 1557–1562. DOI:10.1007/BF01765673. ISSN:0023-2173.
  • Buschbeck، Herbert (2009). "Neue Wege der Hormontherapie in der Gynäkologie" [New ways of hormonal therapy in gynecology]. Deutsche Medizinische Wochenschrift. ج. 60 ع. 11: 389–393. DOI:10.1055/s-0028-1129842. ISSN:0012-0472.
  • Biskind، Morton S. (1935). "Commercial Glandular Products". Journal of the American Medical Association. ج. 105 ع. 9: 667. DOI:10.1001/jama.1935.92760350007009a. ISSN:0002-9955. Progynon-B, Schering Corporation: This is crystalline hydroxyestrin benzoate obtained by hydrogenation of theelin and subsequent conversion to the benzoate. [...] Progynon-B is marketed in ampules containing 1 cc. of a sesame oil solution of hydroxyestrin benzoate of either 2,500, 5,000, 10,000 or 50,000 international units.
  • "Neue Spezialitäten". Klinische Wochenschrift. ج. 44 ع. 23: 1381. 1966. DOI:10.1007/BF01747900. ISSN:0023-2173. NEUE SPEZIALITATEN [...] Progynova. 1 Dragee enthält 2 mg Oestradiolvalerinat (Klimakterium). Hersteller: Schering AG, Berlin 65.
  • Dapunt O (Sep 1967). "Behandlung klimakterischer Beschwerden mit Östradiolvalerianat (Progynova)" [The management of climacteric disorders using estradiol valerate (Progynova)]. Med Klin (بالألمانية). 62 (35): 1356–61 passim. ISSN:0025-8458. PMID:5593020.